Credit: Canva
Cancer is a large group of diseases that can start in almost any organ or tissue of the body when abnormal cells grow uncontrollably, and go beyond their usual boundaries to invade adjoining parts of the body. According to the World Health Organization (WHO), it is the second most common cause of death globally, accounting for millions of deaths every year. Lung, prostate, colorectal, stomach and liver cancer are the most common types of cancer in men, while breast, colorectal, lung, cervical and thyroid cancer are the most common among women. However, these are not necessarily the deadliest forms of cancer.
What makes cancer the deadliest depends upon how many people have it and what percentage of those people actually survive. Cancer researchers determine this on the basis of five-year relative survival. This is the percentage of people who are expected to survive the effects of a given cancer, excluding their risk of other possible causes of death, for five years past a diagnosis. It is also important to note that what makes cancer really deadly is that practically no cure for it. A cure for cancer would imply that there are no cancerous cells remaining in the body.
Here are the 5 deadliest cancers in the U.S., according to SEER five-year relative survival data for cases diagnosed between 2014 and 2020.
1. Pancreatic cancer occurs when cells in your pancreas, a gland in your abdomen that aids digestion, mutate and multiply out of control, forming a tumour. Major risk factors include smoking, obesity, diabetes, chronic pancreatitis, certain genetic mutations and environmental chemical exposure.
2. Esophageal cancer develops in the oesophagus, which is the tube that connects your throat to your stomach.
3. Liver cancer and intrahepatic bile duct cancer originate in the liver or bile ducts, often linked to hepatitis infections, heavy alcohol use, obesity, and aflatoxin exposure.
4. Lung and bronchus cancer primarily caused by smoking, secondhand smoke, and environmental pollutants, affects the lungs and airways, making it the leading cause of cancer death in the US.
5. Acute myeloid leukaemia (AML) is an aggressive blood and bone marrow cancer that progresses rapidly, often linked to genetic mutations, radiation exposure, and certain chemicals.
ALSO READ: Why Are Lifestyle Factors Making Millennials Vulnerable To Cancer?
Credit: iStock
The Donald Trump administration plans to end Medicare Part D premium subsidies after 2026, ending a program that has helped keep prescription drug plan premiums stable, according to the Centers for Medicare & Medicaid Services (CMS).
The decision could affect millions of Americans, particularly those aged 65 and older, who may face higher prescription drug costs beginning next year.
The CMS said its review of insurers' 2027 bids found that health plans now have sufficient experience to accurately price Medicare Part D plans without government support, according to The Wall Street Journal.
The program, to end after 2026, provides insurance companies with an estimated $3.6 billion in subsidies this year to limit premium increases for Part D plans.
"We are stabilizing the market so this bailout is no longer needed. Premiums will go up by less than $10 for most Medicare recipients, with many even seeing lower premiums," CMS Administrator Dr. Mehmet Oz said in a post on X.
"Every Medicare beneficiary still has access to low-cost plans, and we will continue to lower prescription drug prices for every American patient, from more MFN deals to our policy giving seniors access to GLP-1s for $50 a month,” he added.
Around 25 million Americans enrolled in traditional Medicare have stand-alone Part D prescription drug plans, paying an average monthly premium of $36, according to KFF.
Another 31 million beneficiaries receive prescription drug coverage through Medicare Advantage, the privately managed alternative for people aged 65 and older.
The previous Biden administration had introduced the subsidy program ahead of the 2024 presidential election to offset policy changes that would have sharply increased Medicare Part D premiums in 2025.
Dr Oz said that the Biden administration’s approach was “unacceptable” and that it “gave BILLIONS of taxpayer money DIRECTLY to Big Insurance Companies.”
However, it remains unclear how many beneficiaries will pay more or how large those increases will be. Premiums vary by plan, and beneficiaries will have an opportunity to compare and switch coverage during this fall's enrollment period. CMS said premiums for individual plans will be released in September.
AHIP, a major trade group representing health insurers, said it is reviewing the announcement, the New York Times reported.
“At a time of sharply rising prescription drug costs, health plans are focused on keeping Part D coverage and benefits as affordable as possible,” said Chris Bond, a spokesman, in a statement.
A Trump administration official told Bloomberg that the majority of older Americans will see no increase in premiums or may even pay less.
CMS also released preliminary information on 2027 Medicare drug plan bids. The national average monthly bid amount, used to calculate government subsidies for plans, will be $296.05 in 2027.
The agency said the national base beneficiary premium for Medicare Part D will be $41.33 next year. Annual increases will remain capped at 6% through 2029 under provisions of the Inflation Reduction Act.
Credit: X
More than six years after the COVID-19 pandemic devastated the world, newly released personal journals of former National Institute of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci are giving a raw glimpse into the behind-the-scenes discussions, scientific uncertainty, and political tensions that clouded United States' pandemic response.
The 1,141-page collection, released by Senator Rand Paul ahead of Fauci's scheduled Senate testimony, chronicles events from December 2019 through December 2022.
Announcing the release of Fauci's journals, Sen. Rand Paul said, "The American people deserve the truth about what happened during the COVID-19 pandemic. Dr. Fauci's own contemporaneous writings provide an unprecedented window into the decisions, discussions, and uncertainties that shaped the federal response."
The journals have reignited debate over the origins of SARS-CoV-2 and Fauci's role during one of the most challenging public health crises of recent times.
However, experts say that the diaries represent Fauci's personal contemporaneous notes and do not conclusively establish the origin of COVID-19.
One of the biggest revelations is that Anthony Fauci recorded discussions in late January 2020 in which several scientists raised questions about whether SARS-CoV-2 could have originated from a laboratory because of certain genetic features.
The diary shows these possibilities were discussed internally before scientists later concluded that natural spillover was the more likely. The diary does not provide proof that the virus leaked from a lab.
Fauci wrote, "The first infection was in early December and was not connected to the market... Now we know the market was not the source, it was the amplifier. Having said that, somewhere the virus jumped from animals to humans."
Also read: Trump Should Take A Month Off For His Health, Says Bill O'Reilly
The entries reveal Fauci continued receiving updates about the virus's origin while publicly emphasizing the available scientific evidence supporting natural emergence.
After a conference call with leading virologists, Fauci wrote that several experts discussed whether part of the virus genome could have evolved naturally. He listed the participants and summarized the debate over the possibility of a laboratory origin.
Early diary entries describe the outbreak as looking similar to "bad influenza" before severe complications became clear. This reflects the limited knowledge available in January and early February 2020.
Fauci's notes reportedly show he was conflicted about balancing infection control against the educational and mental health consequences of prolonged school closures, highlighting the uncertainty policymakers faced.
The diary documents Fauci's concerns about bureaucratic delays, operational problems, and disagreements within the federal government during the early COVID-19 response, suggesting these challenges complicated public health decision-making.
The entries describe Fauci's dynamic with President Donald Trump, disagreements over masks, hydroxychloroquine, and public messaging, and concerns about how politics affected science.
He wrote, "AMAZING interaction with POTUS... It was a disturbingly rambling discussion since he kept talking about TV ratings, and HC (Hydroxychloroquine), and influenza and virtually everything else as I was trying to keep him on track."
He also wrote about outshining President Trump. "Apparently the WH is very upset that I am being profiled and it looks like I am putting down the POTUS and becoming a star that outshines him. ... Very stressful!!"
He also wrote that Trump praised him. "As usual, POTUS was very warm and friendly with me... 'I love you, Tony. I feel like giving you a big hug.'"
The journals reveal Fauci's obsession with his fame due to widespread media coverage and his efforts to maintain public trust. He wrote, "For better or worse, I am becoming an international celebrity. Calls from all over the world."
He added, "WH press conference picked up by many outlets. Many print profiles and features on me. Ridiculous, too numerous to count! ... Press is going wild with me."
Fauci's diary sparked a lot of responses from politicians and health experts.
He said, "He lied about masks. He lied about social distancing. He lied about transmission. He lied about natural immunity. He lied about the vaccine's capacity to prevent infection."
He added. "Dr. Fauci did incalculable damage to public health and to the public's trust in government. "He prioritized getting on TV over protecting public health."
Credit: X
Olympic hurdler and bobsledder Lolo Jones has revealed that she suffered a debilitating spinal injury during bobsled training, lost bladder control, and was allegedly denied timely medical care, raising serious concerns about athlete health and safety within the U.S. Olympic system.
Jones shared her experience after reports of the the events surrounding a training accident ahead of the 2025 IBSF World Championships in Lake Placid surfaced.
According to the reports, she sustained a severe lower back injury while testing a new bobsled but continued competing because her condition was never diagnosed at the time.
During the training session, Lolo Jones experienced symptoms like intense lower back pain, numbness, leg weakness, foot drop, and loss of bladder control; all of which can be warning signs of cauda equina syndrome, a rare but serious condition caused by compression of nerves at the base of the spinal cord.
It is a medical emergency as delayed treatment can result in permanent paralysis or loss of bladder and bowel function.
Despite these symptoms, Jones alleges she did not receive urgent medical evaluation. Reports claim that when she visited the U.S. Olympic Training Center's sports medicine clinic seeking treatment, her scheduled massage appointment had been canceled, and she was not provided immediate imaging such as an MRI or X-ray.
Convinced she was dealing with a painful but manageable injury, Jones continued to compete in the World Championships, completing multiple high-speed bobsled runs. She later said that had the sled crashed during competition, she could have been left permanently paralysed.
After returning home, Jones reportedly paid for her own MRI, which revealed the extent of the damage. The scan showed a herniated disc, additional disc bulges, and tears involving the L3, L4 and L5 levels of her spine, with leaking spinal fluid. She subsequently underwent spinal surgery at her own expense.
Jones also claims that after surgery she was denied access to training and rehabilitation facilities at the Olympic Training Center, forcing her to fund her own recovery, rehabilitation, travel and training. According to reports, the financial burden exceeded $100,000.
The athlete has since called for greater accountability and reforms in athlete medical care, especially who compete in the Olympics.
In a public statement, Jones wrote that she had "never even been given an X-ray or an MRI" despite her symptoms and said she wanted to help ensure other athletes do not face similar situations.
Experts consider loss of bladder control, leg weakness, numbness around the saddle area, and severe lower back pain to be serious symptoms that need immediate emergency assessment.
Prompt diagnosis, usually with an MRI, and urgent surgery when cauda equina syndrome is confirmed can significantly improve the chances of preserving nerve function and preventing the risk of paralysis.
Jones is one of the few athletes to have competed at both the Summer and Winter Olympics, representing the United States in hurdles and bobsled.
Her latest allegations have sparked renewed discussion about whether elite athletes receive timely access to appropriate medical attention when serious injuries occur.
© 2024 Bennett, Coleman & Company Limited